| Literature DB >> 28099432 |
Chris A Rees1,2, Robert J Flick1,3,4, David Sullivan1, Menard Bvumbwe1, Joseph Mhango1, Mina C Hosseinipour3, Peter N Kazembe1,5.
Abstract
BACKGROUND: Human immunodeficiency virus (HIV) contributes to nearly 20% of all deaths in children under five years of age in Malawi. Expanded coverage of antiretroviral therapy has allowed children to access treatment on an outpatient basis. Little is known about characteristics of the final outpatient encounter prior to mortality in the outpatient setting.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28099432 PMCID: PMC5242418 DOI: 10.1371/journal.pone.0169057
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Consort diagram demonstrating exclusion criteria and patient population selection.
Descriptive clinical characteristics of patients who died in the outpatient setting after their last clinical encounter.
| 46 (10.0) | |
| •I | 43(14.9) |
| •II | 18 (6.3) |
| •III | 73 (25.3) |
| •IV | 154 (53.5) |
| •Pulmonary tuberculosis | 81 (17.6) |
| •Oral/esophageal thrush | 67 (14.6) |
| •Severe acute malnutrition | 62 (13.5) |
| •Kaposi sarcoma | 47 (10.2) |
| •Moderate malnutrition | 42 (9.2) |
| •Pneumocystis pneumonia | 8 (1.7) |
| •Pneumonia | 50 (10.9) |
| •Doing well | 49 (10.7) |
| •Gastroenteritis | 35 (7.6) |
| •Malaria | 27 (5.9) |
| •No | 403 (87.8) |
| •Yes | 56 (12.2) |
*Excludes 25 with missing documented WHO staging in electronic medical record and 46 exposed infants.
Characteristics of visits among patients who died as outpatients compared to patients still alive after their last clinical encounter at Baylor-Malawi.
| Alive (N = 5070) | Died (N = 459) | Odds Ratio (95% CI) | p-value | Adjusted Odds Ratio (95% CI) | p-value | |||
|---|---|---|---|---|---|---|---|---|
| 1.84 | (0.40–5.2) | 0.3 | (0.07–1.1) | 0.65 (0.61–0.70) | <0.0001 | 0.77 (0.72–0.82) | <0.001 | |
| 1.2 | (0.9–2.0) | 0.6 | (0.3–1.2) | 1.03 (1.01–1.04) | <0.0001 | |||
| 0 | (0–1) | 1 | (0–2) | 2.06 (1.86–2.29) | <0.001 | 1.49 (1.31–1.69) | <0.001 | |
| •No | 4,770 | (94.1) | 384 | (83.7) | ||||
| •Yes | 300 | (5.9) | 75 | (16.3) | 3.11 (2.36–4.08) | <0.0001 | 1.46 (1.31–1.69) | <0.001 |
| •No | 3538 | (69.8) | 353 | (76.9) | <0.0001 | |||
| •Yes | 286 | (5.6) | 42 | (9.2) | 1.47 (1.05–2.07) | |||
Clinical characteristics among patients who died as outpatients compared to matched patients who were alive after their last clinical encounter at Baylor-Malawi.
| Alive (N = 5070) | Died (N = 459) | Odds Ratio (95% CI) | p-value | Adjusted Odds Ratio (95% CI) | p-value | |||
|---|---|---|---|---|---|---|---|---|
| 6.8 | (2.6–11.1) | 2.3 | (1.0–7.6) | 0.89 (0.87–0.91) | <0.0001 | |||
| •Male | 2560 | (50.5) | 254 | (55.3) | ||||
| •Female | 2510 | (49.5) | 205 | (44.7) | 0.82 (0.68–0.99) | 0.047 | 0.75 (0.59–0.96) | 0.02 |
| •Within normal limits | 4492 | (94.9) | 223 | (61.1) | <0.0001 | |||
| •Mild | 73 | (1.5) | 16 | (4.4) | 4.41 (2.53–7.71) | 2.55 (1.40–4.65) | 0.002 | |
| •Moderate | 113 | (2.4) | 56 | (15.3) | 9.98 (7.05–14.13) | 4.71 (3.22–6.88) | <0.001 | |
| •Severe | 53 | (1.1) | 70 | (19.2) | 26.6 (18.17–38.96) | 10.83 (7.17–16.37) | <0.001 | |
| •No | 3996 | (78.8) | 276 | (60.1) | <0.0001 | |||
| •Yes | 1074 | (21.2) | 183 | (39.9) | 2.47 (2.02–3.01) | 2.33 (1.82–3.00) | <0.001 | |
| •No | 1537 | (30.3) | 168 | (36.6) | <0.0001 | |||
| •Yes | 3353 | (66.1) | 241 | (52.5) | 0.66 (0.54–0.81) | |||
| •Nevirapine-based (1st line) | 2907 | (86.9) | 217 | (90.4) | 0.112 | |||
| •Protease inhibitor-based (2nd line) | 440 | (13.1) | 23 | (9.6) | 0.7 (0.45–1.09) | |||
| •No | 4937 | (97.4) | 405 | (88.2) | ||||
| •Yes | 131 | (2.6) | 54 | (11.8) | 5.02 (3.60–7.01) | <0.0001 | 1.98 (1.29–3.04) | 0.002 |
| •<50 | 86 | (1.7) | 40 | (8.7) | 6.15 (4.15–9.11) | <0.0001 | ||
| •50–99 | 56 | (1.1) | 24 | (5.2) | 5.67 (3.46–9.27) | |||
| •100–199 | 140 | (2.8) | 31 | (6.8) | 2.93 (1.95–4.40) | |||
| •200–349 | 402 | (7.9) | 33 | (7.2) | 1.09 (0.75–1.58) | |||
| •350–499 | 499 | (9.8) | 37 | (8.1) | 0.98 (0.69–1.40) | |||
| Over 500 | 3887 | (76.7) | 294 | (64.1) | ||||
| •No | 1541 | (71.1) | 30 | (38.5) | <0.0001 | |||
| •Yes | 626 | (28.9) | 48 | (61.5) | 3.94 (2.47–6.27) | |||